Why Is Inovio Pharmaceuticals ( $INO) Stock Up +7.83% Today? $JNJ $IWM $GNTX $MRNA INO gained +7.83% during regular trading hours, rising to $1.24 from a prior-session close of $1.15. The advance reverses a weeklong slide that took shares from $1.28 down to $1.15, suggesting a technical rebound in a volatile small-cap biotech. No company-specific announcement drove the move; positioning appears tied to the upcoming FDA decision on lead DNA medicine INO-3107 for recurrent respiratory papillomatosis. The stock remains a binary catalyst play ahead of the October 30, 2026 PDUFA target action date, with label negotiations expected in September. Traders are watching for FDA regulatory or label updates and the PDUFA outcome as the next major catalysts.